Induction of gene expression in response to globular adiponectin in vascular endothelial cells

Life Sciences

Volumn 85, Issue 11-12, 2009, Pages 457-461

  Tomizawa, Atsuko ^a   Hattori, Yoshiyuki ^a   Kasai, Kikuo ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Adiponectin; Endothelial cells; Gene expression; Signaling pathway

Indexed keywords

ADIPONECTIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ADIPONECTIN; BLOTTING, WESTERN; CELLS, CULTURED; CHEMOKINE CCL2; DNA, COMPLEMENTARY; ENDOTHELIAL CELLS; GENE EXPRESSION; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PROTEIN KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UMBILICAL VEINS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 69349090602     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.07.012     Document Type: Article

References (20)

1. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., and Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemistry Biophysiology Research Communications 257 (1999) 79-83
2. Fruebis J., Tsao T.S., Javorschi S., Ebbets-Reed D., Erickson M.R., Yen F.T., Bihain B.E., and Lodish H.F. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proceeding of National Academy of Science USA 98 (2001) 2005-2010
3. Hattori Y., Hattori S., Akimoto K., Nishikimi T., Suzuki K., Matsuoka H., and Kasai K. Globular adiponectin activates nuclear factor-kappaB and activating protein-1 and enhances angiotensin II-induced proliferation in cardiac fibroblasts. Diabetes 56 (2007) 804-808
4. Hattori Y., Hattori S., and Kasai K. Globular adiponectin activates nuclear factor-{kappa}b in vascular endothelial cells, which in turn induces expression of proinflammatory and adhesion molecule genes. Diabetes Care 229 (2006) 139-141
5. Hattori Y., Nakano Y., Hattori S., Tomizawa A., Inukai K., and Kasai K. High molecular weight adiponectin activates AMPK and suppresses cytokine-induced NF-kappaB activation in vascular endothelial cells. FEBS Letters 582 (2008) 1719-1724
6. Hattori Y., Suzuki M., Hattori S., and Kasai K. Vascular smooth muscle cell activation by glycated albumin (Amadori adducts). Hyperetension 39 (2002) 22-28
7. Haugen F., and Drevon C.A. Activation of nuclear factor-kappaB by high molecular weight and globular adiponectin. Endocrinology 148 (2007) 5478-5486
8. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., Iwahashi H., Kuriyama H., Ouchi N., Maeda K., Nishida M., Kihara S., Sakai N., Nakajima T., Hasegawa K., Muraguchi M., Ohmoto Y., Nakamura T., Yamashita S., Hanafusa T., and Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis Thrombosis Vascular Biology 20 (2000) 1595-1599
9. Kubota N., Terauchi Y., Yamauchi T., Kubota T., Moroi M., Matsui J., Eto K., Yamashita T., Kamon J., Satoh H., Yano W., Froguel P., Nagai R., Kimura S., Kadowaki T., and Noda T. Disruption of adiponectin causes insulin resistance and neointimal formation. Journal of Biological Chemistry 277 (2002) 25863-25866
10. Luo X.H., Guo L.J., Yuan L.Q., Xie H., Zhou H.D., Wu X.P., and Liao E.Y. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Experimental Cell Research 309 (2005) 99-109
11. Maeda N., Shimomura I., Kishida K., Nishizawa H., Matsuda M., Nagaretani H., Furuyama N., Kondo H., Takahashi M., Arita Y., Komuro R., Ouchi N., Kihara S., Tochino Y., Okutomi K., Horie M., Takeda S., Aoyama T., Funahashi T., and Matsuzawa Y. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nature Medicine 8 (2002) 731-737
12. Nakano Y., Tobe T., Choi-Miura N.H., Mazda T., and Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. Journal of Biochemistry (Tokyo) 120 (1996) 803-812
13. Shibata R., Ouchi N., Ito M., Kihara S., Shiojima I., Pimentel D.R., Kumada M., Sato K., Schiekofer S., Ohashi K., Funahashi T., Colucci W.S., and Walsh K. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nature Medicine 10 (2004) 1384-1389
14. Tang C.H., Chiu Y.C., Tan T.W., Yang R.S., and Fu W.M. Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-kappa B pathway. Journal of Immunology 79 (2007) 5483-5492
15. Tomizawa A., Hattori Y., Kasai K., and Nakano Y. Adiponectin induces NF-kappaB activation that leads to suppression of cytokine-induced NF-kappaB activation in vascular endothelial cells: globular adiponectin vs. high molecular weight adiponectin. Diabetes Vascular Disease Research 2 (2008) 123-127
16. Tsao T.S., Tomas E., Murrey H.E., Hug C., Lee D.H., Ruderman N.B., Heuser J.E., and Lodish H.F. Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity: different oligomers activate different signal transduction pathways. Journal of Biological Chemistery 278 (2003) 50810-50817
17. Vaverkova H., Karasek D., Novotny D., Jackuliakova D., Halenka M., Lukes J., and Frohlich J. Positive association of adiponectin with soluble vascular cell adhesion molecule sVCAM-1 levels in patients with vascular disease or dyslipidemia. Athrosclerosis 197 (2008) 725-731
18. Waki H., Yamauchi T., Kamon J., Ito Y., Uchida S., Kita S., Hara K., Hada Y., Vasseur F., Froguel P., Kimura S., Nagai R., and Kadowaki T. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. Journal of Biological Chemistry 278 (2003) 40352-40363
19. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., Yamashita S., Noda M., Kita S., Ueki K., Eto K., Akanuma Y., Froguel P., Foufelle F., Ferre P., Carling D., Kimura S., Nagai R., Kahn B.B., and Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine 8 (2002) 1288-1295
20. Yamauchi T., Kamon J., Waki H., Imai Y., Shimozawa N., Hioki K., Uchida S., Ito Y., Takakuwa K., Matsui J., Takata M., Eto K., Terauchi Y., Komeda K., Tsunoda M., Murakami K., Ohnishi Y., Naitoh T., Yamamura K., Ueyama Y., Froguel P., Kimura S., Nagai R., and Kadowaki T. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. Journal of Biological Chemistry 278 (2003) 2461-2468